CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related Cytopenia

Clinical trial NCT07574073 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07574073
Sponsor: Qi deng
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Anti-CD20 Monoclonal Antibody BTK Inhibitors Immune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia (AIHA)

Start date: 2026-06-01
Primary completion: 2028-05-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.